The maladaptive effects of HIV protease inhibitors (lopinavir/ritonavir) on the rat heart

被引：9
|
作者：
Reyskens, Kathleen M. S. E. [1 ]
Essop, M. Faadiel [1 ]
机构：
[1] Univ Stellenbosch, CMRG, Dept Physiol Sci, ZA-7600 Stellenbosch, South Africa
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2013年 / 168卷 / 03期
基金：
新加坡国家研究基金会;
关键词：
HIV-AIDS; HIV protease inhibitors; Cardiovascular diseases; Ischemia-reperfusion; Metabolism;
D O I：
10.1016/j.ijcard.2013.04.128
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：3047 / 3049
页数：4
相关论文
共 50 条
  • [21] Synthesis of a Hydroxyethylene Dipeptide Isostere, a Core Unit of the HIV Protease Inhibitors Ritonavir and Lopinavir, and Its C-5 Epimer
    Bhaskar, Gopishetti
    Kumar, Anchoori Ravi
    Ramu, Errabelli
    Rao, Batchu Venkateswara
    SYNTHESIS-STUTTGART, 2008, (19): : 3061 - 3064
  • [22] Double boosted protease inhibitors, saquinavir, and lopinavir/ritonavir, in nucleoside pretreated children at 48 weeks
    Kosalaraksa, Pope
    Bunupuradah, Torsak
    Engchanil, Chulapan
    Boonrak, Pitch
    Intasan, Jintana
    Lumbiganon, Pagakrong
    Burger, David
    Ruxrungtham, Kiat
    Schutz, Malte
    Ananworanich, Jintanat
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (07) : 623 - 628
  • [23] Pharmacokinetic Interactions Between the Hepatitis C Virus Protease Inhibitor Boceprevir and Ritonavir-Boosted HIV-1 Protease Inhibitors Atazanavir, Darunavir, and Lopinavir
    Hulskotte, Ellen G. J.
    Feng, Hwa-Ping
    Xuan, Fengjuan
    van Zutven, Marge G. J. A.
    Treitel, Michelle A.
    Hughes, Eric A.
    O'Mara, Edward
    Youngberg, Stephen P.
    Wagner, John A.
    Butterton, Joan R.
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (05) : 718 - 726
  • [24] Pharmacokinetic Interactions Between the HCV Protease Inhibitor MK-5172 and Ritonavir-Boosted HIV Protease Inhibitors (Atazanavir, Lopinavir, Darunavir) in Healthy Volunteers
    Caro, Luzelena
    Talaty, Jennifer E.
    Guo, Zifang
    Fraser, Iain P.
    Davis, Henry U.
    O'Reilly, Terry
    Yeh, Wendy W.
    Butterton, Joan R.
    HEPATOLOGY, 2013, 58 : 442A - 443A
  • [25] HIV-1 subtype influences susceptibility and response to monotherapy with the protease inhibitor lopinavir/ritonavir
    Sutherland, K. A.
    Ghosn, J.
    Gregson, J.
    Mbisa, J. L.
    Chaix, M. L.
    Codar, I. Cohen
    Delfraissy, J. F.
    Delaugerre, C.
    Gupta, R. K.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (01) : 243 - 248
  • [26] Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV
    Pulido, Federico
    Arribas, Jose R.
    Delgado, Rafael
    Cabrero, Esther
    Gonzalez-Garcia, Juan
    Perez-Elias, Maria J.
    Arranz, Alberto
    Portilla, Joaquin
    Pasquau, Juan
    Iribarren, Jose A.
    Rubio, Rafael
    Norton, Michael
    AIDS, 2008, 22 (02) : F1 - F9
  • [27] Successful co-administration of dabigatran etexilate and protease inhibitors ritonavir/lopinavir in a patient with atrial fibrillation
    Barco, Stefano
    Coppens, Michiel
    van den Dool, Erik-Jan
    van de Kerkhof, Daan
    Stroobants, An K.
    Middeldorp, Saskia
    THROMBOSIS AND HAEMOSTASIS, 2014, 112 (04) : 836 - 838
  • [28] The Safety and Efficacy of the Protease Inhibitors Lopinavir/Ritonavir as Monotherapy or Combined with Interferon in COVID-19 Patients
    Kandeel, Mahmoud
    Morsy, Mohamed A. A.
    Abd El-Lateef, Hany M. M.
    Marzok, Mohamed
    El-Beltagi, Hossam S. S.
    Al Khodair, Khalid M. M.
    Albokhadaim, Ibrahim
    Venugopala, Katharigatta N. N.
    PROCESSES, 2023, 11 (02)
  • [29] Clinical pharmacology of HIV protease inhibitors: focus on saquinavir, indinavir, and ritonavir
    Hoetelmans, RMW
    Meenhorst, PL
    Mulder, JW
    Burger, DM
    Koks, CHW
    Beijnen, JH
    PHARMACY WORLD & SCIENCE, 1997, 19 (04): : 159 - 175
  • [30] HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review
    Bierman, Wouter F. W.
    van Agtmael, Michiel A.
    Nijhuis, Monique
    Danner, Sven A.
    Boucher, Charles A. B.
    AIDS, 2009, 23 (03) : 279 - 291
12345